Literature DB >> 19854333

A(1c) control in a primary care setting: self-titrating an insulin analog pre-mix (INITIATEplus trial).

David S Oyer1, Mark D Shepherd, Franklin C Coulter, Anuj Bhargava, Jason Brett, Pei-Ling Chu, Bruce S Trippe.   

Abstract

PURPOSE: To study glycemic control and hypoglycemia development upon initiation of insulin through a self-titration schedule in a 24-week trial, conducted with 4875 insulin-naïve patients with poorly controlled type 2 diabetes, predominantly in a primary care setting.
METHODS: Subjects initiated twice-daily biphasic insulin aspart 70/30 with 6 units prebreakfast and 6 units presupper, self-titrating according to self-measured blood glucose values. Subjects were randomized (1:1:1) to telephone counseling provided by a registered dietician: no counseling (NC), 1 counseling session (1C), or 3 sessions (3C).
RESULTS: Mean baseline HbA(1c) (9.9% across groups) decreased approximately 2.5% to 7.49% + or - 1.48, 7.48% + or - 1.50, and 7.44% + or - 1.46 in the NC, 1C, and 3C groups, respectively. Within these groups, a hemoglobin A(1c) (HbA(1c)) value <7% was achieved by 40.2%, 41.6%, and 41.8% of subjects, respectively. Eight-point blood glucose profiles were substantially improved from baseline for all groups. Hypoglycemia was experienced by 10.2%-11.4% of the subjects in each group. Rates of minor and major hypoglycemia were low but decreased as dietary counseling increased (minor hypoglycemia: 56 vs 50 vs 45 episodes per 100 patient-years; major hypoglycemia, 9 vs 6 vs 4 episodes per 100 patient-years, for the NC vs 1C vs 3C groups, respectively; P <.001, 3C vs NC). Weight increased by 3.13, 3.40, and 2.88 kg for the NC, 1C, and 3C groups, respectively.
CONCLUSION: In the primary care setting, self-titration of biphasic insulin aspart 70/30 was effective in achieving recommended HbA(1c) goals even with minimal dietary counseling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19854333     DOI: 10.1016/j.amjmed.2008.12.026

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  12 in total

Review 1.  Initiating insulin in patients with type 2 diabetes.

Authors:  Adrian N C Lau; Terence Tang; Henry Halapy; Kevin Thorpe; Catherine H Y Yu
Journal:  CMAJ       Date:  2012-04-02       Impact factor: 8.262

2.  Stepwise self-titration of oral glucose-lowering medication using a mobile telephone-based telehealth platform in type 2 diabetes: a feasibility trial in primary care.

Authors:  Alexander Nagrebetsky; Mark Larsen; Anthea Craven; Jane Turner; Nicky McRobert; Elizabeth Murray; Oliver Gibson; Andrew Neil; Lionel Tarassenko; Andrew Farmer
Journal:  J Diabetes Sci Technol       Date:  2013-01-01

3.  Are analogue insulins superior to human insulin in clinical practice?

Authors:  Jeffrey S Freeman
Journal:  Curr Diab Rep       Date:  2010-06       Impact factor: 4.810

4.  Automated symptom and treatment side effect monitoring for improved quality of life among adults with diabetic peripheral neuropathy in primary care: a pragmatic, cluster, randomized, controlled trial.

Authors:  A S Adams; J A Schmittdiel; A Altschuler; E A Bayliss; R Neugebauer; L Ma; W Dyer; J Clark; B Cook; D Willyoung; M Jaffe; J D Young; E Kim; J M Boggs; L A Prosser; E Wittenberg; B Callaghan; M Shainline; R M Hippler; R W Grant
Journal:  Diabet Med       Date:  2018-11-07       Impact factor: 4.359

5.  Can a tool that automates insulin titration be a key to diabetes management?

Authors:  Richard M Bergenstal; Eran Bashan; Margaret McShane; Mary Johnson; Israel Hodish
Journal:  Diabetes Technol Ther       Date:  2012-05-08       Impact factor: 6.118

Review 6.  Ten years of experience with biphasic insulin aspart 30: from drug development to the latest clinical findings.

Authors:  Andreas Liebl; Vinay Prusty; Paul Valensi; Ryuzo Kawamori; Jens Sandahl Christiansen; Andrew J Palmer; Per Balschmidt; Robert Ligthelm; Viswanathan Mohan
Journal:  Drugs       Date:  2012-07-30       Impact factor: 9.546

7.  An educational program for insulin self-adjustment associated with structured self-monitoring of blood glucose significantly improves glycemic control in patients with type 2 diabetes mellitus after 12 weeks: a randomized, controlled pilot study.

Authors:  Daniel Dutra Romualdo Silva; Adriana Aparecida Bosco
Journal:  Diabetol Metab Syndr       Date:  2015-01-15       Impact factor: 3.320

8.  Insulin degludec in a simple or stepwise titration algorithm in a Japanese population of patients with type 2 diabetes: a randomized, 26-week, treat-to-target trial.

Authors:  Takashi Kadowaki; Hideaki Jinnouchi; Kohei Kaku; Malene L Hersløv; Jacob Hyllested-Winge; Shuji Nakamura
Journal:  Diabetol Int       Date:  2016-09-02

9.  Subject-driven titration of biphasic insulin aspart 30 twice daily is non-inferior to investigator-driven titration in Chinese patients with type 2 diabetes inadequately controlled with premixed human insulin: A randomized, open-label, parallel-group, multicenter trial.

Authors:  Wenying Yang; Lvyun Zhu; Bangzhu Meng; Yu Liu; Wenhui Wang; Shandong Ye; Li Sun; Heng Miao; Lian Guo; Zhanjian Wang; Xiaofeng Lv; Quanmin Li; Qiuhe Ji; Weigang Zhao; Gangyi Yang
Journal:  J Diabetes Investig       Date:  2015-05-25       Impact factor: 4.232

10.  Effects of Age on Glycemic Control in Patients With Type 2 Diabetes Treated with Insulin Detemir: A Post-Hoc Analysis of the PREDICTIVE™ 303 Study.

Authors:  Anuj Bhargava; Vicky Chan; Edward S Kimball; David S Oyer
Journal:  Drugs Aging       Date:  2016-02       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.